immunitoAI Raises $6.1M in Series A to Scale AI-Driven Antibody Development Led by Ashish Kacholia.
Amount Raised
$6.1 Million
Round Type
Series A
BengaluruBiotechnologyArtificial IntelligenceInvestors
Description
Bengaluru-based immunitoAI has secured $6.1 million in a Series A funding round to enhance its AI-led antibody therapeutics pipeline. The round was led by Ashish Kacholia, who contributed approximately $3 million. The new funding will support the company's efforts in developing proprietary antibodies as part of its intellectual property portfolio. This funding follows earlier seed and bridge funding of about $1.8 million.
Quick answer
immunitoAI raised $6.1 Million in a Series A round, dated November 26, 2025. Investors: Ashish Kacholia, Jj Family, 3one4 Capital, AC Ventures, Pi Ventures, Anicut Capital, Lvx and Jito Incubation & Innovation Foundation (Jiif). immunitoAI is based in Bengaluru, Karnataka, India.
- How much did immunitoAI raise?
- immunitoAI raised $6.1 Million in a Series A round on November 26, 2025.
- Who invested in immunitoAI?
- Ashish Kacholia, Jj Family, 3one4 Capital, AC Ventures, Pi Ventures, Anicut Capital, Lvx and Jito Incubation & Innovation Foundation (Jiif) are named as investors in this round.
- What does immunitoAI do?
- immunitoAI is a Bengaluru-based biotech startup that develops antibody therapeutics using generative AI models.
- Where is immunitoAI based and how big is it?
- immunitoAI is based in Bengaluru, Karnataka, India. Fundz records about 23 employees.
- Who are the decision-makers at immunitoAI?
- Fundz holds 1 contact at immunitoAI. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Artificial Intelligence around the same time
Companies in the same sectors as immunitoAI that raised within 45 days of this round, from Fundz verified event records.
- IMVARIA raised an undisclosed amount (Funding Round) on January 8, 2026.
- Carna raised $8M (Funding Round) on January 8, 2026.
- BrightHeart raised $13M (Series A) on January 8, 2026.
- Prudentia Sciences raised $20M (Series A) on January 7, 2026.
- Biographica raised $9.4M (Funding Round) on January 7, 2026.
- Evom AI raised an undisclosed amount (Seed) on January 7, 2026.
Who to call at immunitoAI, and when
A new round usually means immunitoAI is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day immunitoAI raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at immunitoAI, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at immunitoAI. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment immunitoAI raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Funding Insights
What this usually meansimmunitoAI raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.